US Stock MarketDetailed Quotes

EMR Emerson Electric

Watchlist
  • 123.260
  • +0.880+0.72%
Trading Dec 19 10:09 ET
70.20BMarket Cap35.94P/E (TTM)

Emerson Electric Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Emerson Electric Q4 2024 Earnings Date

Currency：USDNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
4.56B
4.62B
+54.04M
Beat Est.
+11.61%
+12.93%
+1.18%
EPS
1.15
1.73
+0.58
Beat Est.
-11.09%
+34.11%
+50.83%
Analyst Rating
Buy

Dec 19, 2024

Emerson Electric Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 19 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 4.529B--
--2025/Q1-- / 4.248B--
Nov 5, 20242024/Q44.619B / 4.565B--
Aug 7, 20242024/Q34.380B / 4.439B--
May 8, 20242024/Q24.376B / 4.290B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 4.529B--
--2025/Q1-- / 4.248B--
Nov 5, 20242024/Q44.619B / 4.565B--
Aug 7, 20242024/Q34.380B / 4.439B--
May 8, 20242024/Q24.376B / 4.290B--

Unlock Free Earnings Estimates

Emerson Electric Earnings Reports

  • Emerson Electric | 10-K: FY2024 Annual Report

    Nov 12 09:30 ET

  • Emerson Electric | 8-K: Emerson Reports Fourth Quarter and Full Year 2024 Results; Provides Initial 2025 Outlook

    Nov 5 06:56 ET

  • Emerson Electric | 10-Q: Q3 2024 Earnings Report

    Aug 7 07:01 ET

  • Emerson Electric | 8-K: Emerson Reports Third Quarter 2024 Results; Updates 2024 Outlook

    Aug 7 07:01 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Halozyme Therapeutics
    HALO
    +2.18%
    Teradata Corp
    TDC
    +1.06%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +1.08%
    eBay
    EBAY
    +0.90%
    Hutchmed (China)
    HCM
    +0.83%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 19, 2024

    Buy

    • Buy

      63.16%

    • Hold

      31.58%

    • Sell

      5.26%

    Price Target

    No Data

    Investment Theme Artificial Intelligence
    Artificial Intelligence
    Intraday+0.78%
    Dividend Aristocrats
    Dividend Aristocrats
    Intraday-0.35%